BG107066A - Male contraceptive formulation comprising norethisterone - Google Patents

Male contraceptive formulation comprising norethisterone

Info

Publication number
BG107066A
BG107066A BG107066A BG10706602A BG107066A BG 107066 A BG107066 A BG 107066A BG 107066 A BG107066 A BG 107066A BG 10706602 A BG10706602 A BG 10706602A BG 107066 A BG107066 A BG 107066A
Authority
BG
Bulgaria
Prior art keywords
norethisterone
male contraceptive
testosterone
males
progestin
Prior art date
Application number
BG107066A
Other languages
Bulgarian (bg)
English (en)
Inventor
Eberhard Nieschlag
Axel Kamischke
Michael Oettel
Alexander Ruebig
Ekkerhard Schillinger
Ursula - Friederike HABENICHT
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of BG107066A publication Critical patent/BG107066A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
BG107066A 2000-02-15 2002-09-05 Male contraceptive formulation comprising norethisterone BG107066A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50372900A 2000-02-15 2000-02-15
EP00200493 2000-02-15
PCT/IB2001/000188 WO2001060376A1 (en) 2000-02-15 2001-02-15 Male contraceptive formulation comprising norethisterone

Publications (1)

Publication Number Publication Date
BG107066A true BG107066A (en) 2003-05-30

Family

ID=26071832

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107066A BG107066A (en) 2000-02-15 2002-09-05 Male contraceptive formulation comprising norethisterone

Country Status (26)

Country Link
EP (2) EP1666044B1 (de)
JP (1) JP2003522795A (de)
KR (1) KR20020086905A (de)
CN (1) CN1423560A (de)
AT (2) ATE355844T1 (de)
AU (1) AU2001230447A1 (de)
BG (1) BG107066A (de)
BR (1) BR0108411A (de)
CA (1) CA2398063A1 (de)
CY (1) CY1106639T1 (de)
CZ (1) CZ20022691A3 (de)
DE (2) DE60127103T2 (de)
DK (1) DK1267885T3 (de)
EE (1) EE200200454A (de)
ES (1) ES2282230T3 (de)
HK (1) HK1049442B (de)
HU (1) HUP0300128A3 (de)
IL (1) IL151219A0 (de)
MX (1) MXPA02007675A (de)
NO (1) NO20023607L (de)
PL (1) PL357185A1 (de)
PT (1) PT1267885E (de)
RU (1) RU2002124602A (de)
SI (1) SI1267885T1 (de)
SK (1) SK11602002A3 (de)
WO (1) WO2001060376A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10234525A1 (de) * 2002-07-25 2004-02-05 Schering Ag Zusammensetzung, enthaltend ein androgenes 11ß-Halogensteroid und ein Gestagen sowie männliches Kontrazeptivum auf Basis dieser Zusammensetzung
TW200404552A (en) * 2002-05-30 2004-04-01 Akzo Nobel Nv Self administered contraception
PL373808A1 (en) 2002-07-24 2005-09-19 Schering Aktiengesellschaft Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids
CN1671394A (zh) * 2002-07-25 2005-09-21 舍林股份公司 包含雄激素性11β－卤素甾体和孕激素的组合物以及基于该组合物的雄性避孕药
CN101352443B (zh) * 2007-07-23 2011-01-12 中国科学院动物研究所 哺乳动物雄性不育剂
US10912762B2 (en) 2018-03-23 2021-02-09 Laboratoires Major Non-hormonal compositions and methods for male contraception

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714420A1 (de) * 1976-06-01 1977-12-08 Int Pregnancy Advisory Service Antikonzeptionsmittel zur verabreichung an mann und frau in einer gemeinsamen verabreichungspackung
US4210644A (en) 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
US5035891A (en) 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
CN1102095A (zh) * 1993-10-30 1995-05-03 浙江医科大学 长效雄激素类制剂——十一酸睾丸注射液
DE19650352A1 (de) * 1996-12-04 1998-07-30 Jenapharm Gmbh Oral wirksames Kombinationspräparat zur Kontrazeption für den Mann

Also Published As

Publication number Publication date
SI1267885T1 (sl) 2007-08-31
ATE355844T1 (de) 2007-03-15
PL357185A1 (en) 2004-07-26
RU2002124602A (ru) 2004-03-10
KR20020086905A (ko) 2002-11-20
MXPA02007675A (es) 2004-02-26
HUP0300128A3 (en) 2004-03-29
EP1267885B1 (de) 2007-03-07
HUP0300128A2 (en) 2003-05-28
CA2398063A1 (en) 2001-08-23
CZ20022691A3 (cs) 2003-01-15
CN1423560A (zh) 2003-06-11
EP1666044A1 (de) 2006-06-07
DE60127103D1 (de) 2007-04-19
JP2003522795A (ja) 2003-07-29
DE60142647D1 (de) 2010-09-02
BR0108411A (pt) 2003-03-11
PT1267885E (pt) 2007-05-31
HK1049442B (zh) 2007-06-15
EE200200454A (et) 2003-12-15
SK11602002A3 (sk) 2003-03-04
ES2282230T3 (es) 2007-10-16
IL151219A0 (en) 2003-04-10
AU2001230447A1 (en) 2001-08-27
NO20023607D0 (no) 2002-07-30
WO2001060376A1 (en) 2001-08-23
EP1666044B1 (de) 2010-07-21
NO20023607L (no) 2002-10-15
ATE474580T1 (de) 2010-08-15
DE60127103T2 (de) 2007-11-22
HK1049442A1 (en) 2003-05-16
EP1267885B8 (de) 2007-06-20
DK1267885T3 (da) 2007-07-09
CY1106639T1 (el) 2012-01-25
EP1267885A1 (de) 2003-01-02

Similar Documents

Publication Publication Date Title
GEP20053586B (en) Selective Androgen Receptor Modulators and Pharmaceutical Compositions Containing the Same
IL188250A0 (en) Dosage unit for inhibiting ovulation comprising drospirenone and a complex between ethinyl estradiol and cyclodextrine
CY1106639T1 (el) Τυποποιηση αντισυλληπτικου για ανδρες που περιλαμβανει νορεθιστερονη
AU7649701A (en) 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents
CA2084891A1 (en) Methods and formulations for use in inhibiting conception and in treating benign gynecological disorders
WO2002009719A1 (fr) Agents antitumoraux
HUP0102483A2 (hu) Androszt-5-én-3béta, 17béta-diolt tartalmazó gyógyszerkészítmények
DE122007000011I1 (de) Feste Arzneiformen, enthaltend Clathrate vom steroidalen Sexualhormon Ethinylestradiol
WO2001003687A3 (en) Method and compositions for inhibiting biosynthesis or bioactivity of endogenous steroid sex hormones in humans
DE59805902D1 (de) Nichtestrogene derivate des estradiols mit antioxidativer aktivität
WO2001040255A3 (en) 14,15-beta-methylene substituted androgens
IL153540A0 (en) THE USE OF 7beta-HYDROXY-STEROID DERIVATIVES FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS
AU1967300A (en) Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11
AR027526A1 (es) Formulacion anticonceptiva masculina que comprende noretisterona
JP2003522795A5 (de)
JP2005532336A (ja) 新規なエトノゲストレルエステルの使用
GB9807809D0 (en) Compositions comprising ethisterone or its derivatives
AU1047002A (en) 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds